Andrew A. F. Hack insider trades
Open-market stock purchases and sales by Andrew A. F. Hack, Unknown at Mersana Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2017.
Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +168%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $108K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $373K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $70.7K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $163K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $159K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $124K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $22.3K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $261K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $123K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $211K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $62.2K |
Companies traded
- MRSN Mersana Therapeutics, Inc: 18 buys, last Jan 6, 2026
- NUVL Nuvalent, Inc: 2 buys, 3 sales, last Dec 11, 2024
- DVAX Dynavax Technologies Corp: 1 buy, 8 sales, last Aug 8, 2023
- MRSN] Mersana Therapeutics, Inc: 3 buys, last Jun 11, 2021
- ALNA Allena Pharmaceuticals, Inc: other filings, last Nov 17, 2020
- AVIR Atea Pharmaceuticals, Inc: 1 buy, last Nov 3, 2020
- BLSA BCLS Acquisition Corp: other filings, last Oct 26, 2020
- EDIT Editas Medicine, Inc: 23 sales, last Nov 23, 2018